Disrupted in Renal Carcinoma 2 (DIRC2) (Middle Region) Peptid
Kurzübersicht für Disrupted in Renal Carcinoma 2 (DIRC2) (Middle Region) Peptid (ABIN8098989)
Target
Quelle
Applikation
-
-
Protein Region
- Middle Region
-
Verwendungszweck
- DIRC2 Peptide - middle region
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti-DIRC2 antibody ( ARP50133_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- DIRC2 (Disrupted in Renal Carcinoma 2 (DIRC2))
-
Hintergrund
-
Background Information: DIRC2 is a membrane-bound protein from the major facilitator superfamily of transporters. Disruption of DIRC2 by translocation has been associated with haplo-insufficiency and renal cell carcinomas. Alternatively spliced transcript variants have been described, but their biological validity has not yet been determined.This gene encodes a membrane-bound protein from the major facilitator superfamily of transporters. Disruption of this gene by translocation has been associated with haplo-insufficiency and renal cell carcinomas. Alternatively spliced transcript variants have been described, but their biological validity has not yet been determined. Sequence Note: The RefSeq transcript and protein were derived from genomic sequence and transcripts to make the sequence consistent with the reference genome assembly. The genomic coordinates used for the transcript record were based on alignments.
Alternative Symbols: FLJ14784, RCC4
-
Molekulargewicht
- 52kDa
-
Gen-ID
- 84925
-
NCBI Accession
- NP_116228
-
UniProt
- Q96SL1
Target
-